Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

'Countermeasure' Devices Needed For Infants, FDA Says – Just In Case

This article was originally published in The Gray Sheet

Executive Summary

The U.S. needs devices specifically designed for infants for its Strategic National Stockpile, FDA officials said at a Feb. 15-16 meeting.

You may also be interested in...



News In Brief

Caution on robotic surgery from Ob/Gyn group. FDA gets closer to gaining access to most of fiscal 2013 user fees. More news.

Regulatory News In Brief

New guidance, rules and more from FDA and Congress.

Key House Health Subcommittee Will Have New Leaders; Rep. Stark Loses Election Bid

House veteran Pete Stark, D-Calif., who served as ranking member of the House Ways and Means Health Subcommittee, was defeated in his re-election bid on Nov. 6. And Wally Herger, R-Calif., who chaired the subcommittee, already announced his plans to retire earlier this year.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT030990

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel